Talphera, Inc. (NASDAQ:TLPH - Get Free Report)'s share price dropped 1.5% on Friday . The company traded as low as $1.3140 and last traded at $1.35. Approximately 89,522 shares were traded during mid-day trading, a decline of 80% from the average session volume of 441,854 shares. The stock had previously closed at $1.37.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on TLPH shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Talphera in a research report on Friday, July 17th. Westpark Capital assumed coverage on Talphera in a report on Thursday, April 30th. They issued a "buy" rating and a $3.00 price target for the company. Zacks Research upgraded Talphera to a "hold" rating in a research note on Monday, June 8th. Finally, HC Wainwright began coverage on shares of Talphera in a report on Friday, June 5th. They set a "buy" rating and a $3.00 price objective on the stock. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Talphera currently has a consensus rating of "Hold" and a consensus target price of $3.00.
View Our Latest Report on TLPH
Talphera Stock Down 1.5%
The firm has a market capitalization of $70.06 million, a price-to-earnings ratio of -4.35 and a beta of 0.70. The company's 50 day moving average price is $1.03 and its 200 day moving average price is $0.93.
Talphera (NASDAQ:TLPH - Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.03. As a group, analysts expect that Talphera, Inc. will post -0.26 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the company. Cantor Fitzgerald L. P. acquired a new position in Talphera in the 4th quarter worth approximately $658,000. Diadema Partners LP purchased a new position in Talphera during the 4th quarter worth approximately $156,000. Renaissance Technologies LLC lifted its stake in Talphera by 412.6% during the 4th quarter. Renaissance Technologies LLC now owns 257,380 shares of the company's stock valued at $293,000 after acquiring an additional 207,166 shares during the period. Geode Capital Management LLC lifted its stake in Talphera by 107.0% during the 4th quarter. Geode Capital Management LLC now owns 342,987 shares of the company's stock valued at $391,000 after acquiring an additional 177,294 shares during the period. Finally, Nantahala Capital Management LLC boosted its holdings in shares of Talphera by 75.3% in the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company's stock valued at $3,120,000 after acquiring an additional 1,500,000 shares during the last quarter. 37.67% of the stock is currently owned by hedge funds and other institutional investors.
Talphera Company Profile
(
Get Free Report)
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Talphera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Talphera wasn't on the list.
While Talphera currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
